Arnold Monto

Looking at 10 years of data, experts recommend improvements to the flu vaccine

Q&A with Arnold Monto

According to a new study published in the journal Clinical Infectious Diseases, while there have been major advances over the last decade in an effort to improve the effectiveness of seasonal influenza vaccine, innovative approaches are needed to significantly improve vaccine effectiveness. Study author Arnold Monto, professor of Epidemiology at the University of Michigan School of Public Health, discusses the findings.

Arnold Monto Receives Lifetime Achievement Award for Illustrious Contributions to Respiratory Virus Disease Research

For outstanding contributions to respiratory virus disease research over the course of his career, Dr. Arnold Monto, the Thomas Francis, Jr. Collegiate Professor of Public Health, has received the Lifetime Achievement Award from the International Society for Influenza and other Respiratory Virus Diseases (ISIRV).

4 Myths about What It Means for a Vaccine to Be 'FDA Approved'

Arnold Monto Quoted in HuffPost

A recurring sentiment among some in the vaccine-hesitant community is a desire to wait to receive any of the three available COVID-19 vaccines until they have been officially approved by the Food and Drug Administration. And while the FDA has authorized the Pfizer, Moderna and Johnson & Johnson vaccines―and is expected to also approve each one in turn―for many people, the difference between “authorized” and “approved” has been confusing.

Frequent Seasonal Coronavirus Reinfections Hint at Possibility of Endemic COVID-19

New research from Joshua Petrie

Reinfections of seasonal coronaviruses are frequent, according to new research that suggests that the coronavirus behind the current pandemic could also produce reinfections.

States Lift Restrictions Gradually Amid Fears of New Variant

Arnold Monto quoted by ABC News

Several states are loosening their coronavirus restrictions on restaurants and other businesses because of improved infection and hospitalization numbers but are moving cautiously, in part because of the more contagious variant taking hold.

Does Getting the Covid-19 Vaccine Stop You Spreading It? Scientists Don't Know Yet.

Arnold Monto featured in the Wall Street Journal

The Covid-19 vaccines authorized in the U.S. are approximately 95% effective at preventing people from getting sick with symptoms, according to Pfizer and Moderna, the companies that produce them. But scientists are still studying whether vaccination prevents transmission to others.